The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Uterine Cervical Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Uterine Cervical Neoplasms


High impact information on Uterine Cervical Neoplasms


Chemical compound and disease context of Uterine Cervical Neoplasms


Biological context of Uterine Cervical Neoplasms


Anatomical context of Uterine Cervical Neoplasms


Gene context of Uterine Cervical Neoplasms


Analytical, diagnostic and therapeutic context of Uterine Cervical Neoplasms


  1. Volume-sensitive chloride channels associated with human cervical carcinogenesis. Chou, C.Y., Shen, M.R., Wu, S.N. Cancer Res. (1995) [Pubmed]
  2. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia. Dellas, A., Schultheiss, E., Almendral, A.C., Gudat, F., Oberholzer, M., Feichter, G., Moch, H., Torhorst, J. Int. J. Cancer (1997) [Pubmed]
  3. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Fujimoto, J., Toyoki, H., Sato, E., Sakaguchi, H., Tamaya, T. Br. J. Cancer (2004) [Pubmed]
  4. Amifostine and combined-modality therapeutic approaches. Mehta, M.P. Semin. Oncol. (1999) [Pubmed]
  5. Sacral resection for control of pelvic tumors. Temple, W.J., Ketcham, A.S. Am. J. Surg. (1992) [Pubmed]
  6. Prognostic value of estrogen receptors in cancer of the uterine cervix. Martin, J.D., Hännel, R., McCartney, A.J., Woodings, T. N. Engl. J. Med. (1982) [Pubmed]
  7. Viruses in human cancers. zur Hausen, H. Science (1991) [Pubmed]
  8. Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens. Notter, M.F., Docherty, J.J. J. Natl. Cancer Inst. (1976) [Pubmed]
  9. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Crook, T., Wrede, D., Tidy, J.A., Mason, W.P., Evans, D.J., Vousden, K.H. Lancet (1992) [Pubmed]
  10. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Logié, A., Dunois-Lardé, C., Rosty, C., Levrel, O., Blanche, M., Ribeiro, A., Gasc, J.M., Jorcano, J., Werner, S., Sastre-Garau, X., Thiery, J.P., Radvanyi, F. Hum. Mol. Genet. (2005) [Pubmed]
  11. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. Papadimitriou, C.A., Sarris, K., Moulopoulos, L.A., Fountzilas, G., Anagnostopoulos, A., Voulgaris, Z., Gika, D., Giannakoulis, N., Diakomanolis, E., Dimopoulos, M.A. J. Clin. Oncol. (1999) [Pubmed]
  12. Evaluation of the pharmacological benefit and determination of the influencing factors of intraarterial cis-diamminedichloroplatinum administration in patients with uterine cervical cancer. Hecquet, B., Vennin, P., Fournier, C., Poissonnier, B. Cancer Res. (1987) [Pubmed]
  13. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Olive, P.L., Aquino-Parsons, C., MacPhail, S.H., Liao, S.Y., Raleigh, J.A., Lerman, M.I., Stanbridge, E.J. Cancer Res. (2001) [Pubmed]
  14. Newly established uterine cervical cancer cell line (SKG-III) with Regan isoenzyme, human chorionic gonadotropin beta-subunit, and pregnancy-specific beta 1-glycoprotein phenotypes. Nozawa, S., Udagawa, Y., Ohta, H., Kurihara, S., Fishman, W.H. Cancer Res. (1983) [Pubmed]
  15. Endogenous tumor necrosis factor functions as a resistant factor against adriamycin. Maeda, M., Watanabe, N., Okamoto, T., Tsuji, N., Niitsu, Y. Int. J. Cancer (1994) [Pubmed]
  16. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Kim, Y.B., Kim, G.E., Pyo, H.R., Cho, N.H., Keum, K.C., Lee, C.G., Seong, J., Suh, C.O., Park, T.K. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  17. Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression. Marzano, R., Corrado, G., Merola, R., Sbiroli, C., Guadagni, F., Vizza, E., Del Nonno, F., Carosi, M., Galati M, M., Sperduti, I., Cianciulli, A.M. Eur. J. Cancer (2004) [Pubmed]
  18. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers. Fujimoto, J., Sakaguchi, H., Hirose, R., Ichigo, S., Tamaya, T. Br. J. Cancer (1999) [Pubmed]
  19. A free radical initiator, 2,2'-azobis (2-aminopropane) dihydrochloride enhances hyperthermia-induced apoptosis in human uterine cervical cancer cell lines. Yuki, H., Kondo, T., Zhao, Q.L., Fujiwara, Y., Tanabe, K., Ogawa, R., Nakashima, A., Fushiki, H., Fujimura, M., Saito, S. Free Radic. Res. (2003) [Pubmed]
  20. Quantitative determination of 3,3'-diindolylmethane in urine of individuals receiving indole-3-carbinol. Sepkovic, D.W., Bradlow, H.L., Bell, M. Nutrition and cancer. (2001) [Pubmed]
  21. Ifosfamide-induced neurotoxicity. Curtin, J.P., Koonings, P.P., Gutierrez, M., Schlaerth, J.B., Morrow, C.P. Gynecol. Oncol. (1991) [Pubmed]
  22. Folate and cancer: a review of the literature. Glynn, S.A., Albanes, D. Nutrition and cancer. (1994) [Pubmed]
  23. A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes. Okada, Y., Yahata, G., Takeuchi, S., Seidoh, T., Tanaka, K. Jpn. J. Cancer Res. (1989) [Pubmed]
  24. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Kersemaekers, A.M., Fleuren, G.J., Kenter, G.G., Van den Broek, L.J., Uljee, S.M., Hermans, J., Van de Vijver, M.J. Clin. Cancer Res. (1999) [Pubmed]
  25. Induction of heat shock protein 72 synthesis by endogenous tumor necrosis factor via enhancement of the heat shock element-binding activity of heat shock factor 1. Watanabe, N., Tsuji, N., Akiyama, S., Sasaki, H., Okamoto, T., Kobayashi, D., Sato, T., Hagino, T., Yamauchi, N., Niitsu, Y., Nakai, A., Nagata, K. Eur. J. Immunol. (1997) [Pubmed]
  26. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Gaffney, D.K., Haslam, D., Tsodikov, A., Hammond, E., Seaman, J., Holden, J., Lee, R.J., Zempolich, K., Dodson, M. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  27. Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers. Fujimoto, J., Aoki, I., Toyoki, H., Khatun, S., Tamaya, T. Ann. Oncol. (2002) [Pubmed]
  28. Epigenetic and genetic alternation of PTEN in cervical neoplasm. Cheung, T.H., Lo, K.W., Yim, S.F., Chan, L.K., Heung, M.S., Chan, C.S., Cheung, A.Y., Chung, T.K., Wong, Y.F. Gynecol. Oncol. (2004) [Pubmed]
  29. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. Stenman, J., Lintula, S., Hotakainen, K., Vartiainen, J., Lehväslaiho, H., Stenman, U.H. Int. J. Cancer (1997) [Pubmed]
  30. The normal caliber of the adult female urethra. . Uehling, D.T. J. Urol. (1978) [Pubmed]
  31. Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears. Kawai, K., Yaginuma, Y., Tsuruoka, H., Griffin, M., Hayashi, H., Ishikawa, M. Eur. J. Cancer (1998) [Pubmed]
  32. Correlations of dose and time-dose-fractionation factors (TDF) with treatment results and side effects in cancer of the uterine cervix. Yudelev, M., Kuten, A., Tatcher, M., Rubinov, R., Karmeli, R., Cohen, Y., Robinson, E. Gynecol. Oncol. (1986) [Pubmed]
  33. Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Rose, P.G., Blessing, J.A., Buller, R.E., Mannel, R.S., Webster, K.D. Gynecol. Oncol. (2003) [Pubmed]
WikiGenes - Universities